We're very excited to announce our new impact factor! Congrats to our editors, reviewers, and authors. And an extra special thanks to our readers and the
@atscommunity
for helping our impact grow.
We're very excited to announce our new impact factor! Congrats to our editors, reviewers, and authors. And an extra special thanks to our readers and the
@atscommunity
for helping our impact grow.
An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline
🔓 Open Access
🔗
Congratulations to Dr. Fernando J. Martinez the new editor-in-chief of the
#AJRCCM
!
Dr. Martinez succeeds Jadwiga Wedzicha, MD, ATSF. His editorship will begin Jan. 1, 2022.
🔗
📌 Bookmark our COVID-19 landing page to stay up to date on all of the research published by ATS Journals pertaining to the Coronavirus pandemic.
This page will be updated to include papers from all 4 ATS publications.
🔗
@atscommunity
@ATS_Assemblies
Expiratory Muscle Activity Counteracts Positive End-Expiratory Pressure and Is Associated with Fentanyl Dose in Patients with Acute Respiratory Distress Syndrome
Neuromuscular blockade in ARDS makes PEEP more effective
@Gicobellani
🔗
With deepest regret, we announce the death of Gavin Donaldson, Ph.D. Gavin was the Journal’s Statistical Editor for 8 years and the first Statistical Deputy Editor. His kindness and support of the Editors and staff made him a treasured colleague. He will be missed.
E-Cigarette Use Causes a Unique Innate Immune Response in the Lung, Involving Increased Neutrophilic Activation and Altered Mucin Secretion, by
@mkesimer
et al.
@atscommunity
Lung Recruiting Effect of Prone Positioning in Spontaneously Breathing Patients with COVID-19 Assessed by Electrical Impedance Tomography
🔓 Open Access
🔗
The Blue Journal thanks Nida Qadir, MD, for her contribution to the January 1 issue
An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline
@NidaQadirMD
Mechanical Ventilation in ARDS: Insights into Opening the Lung and Driving Pressure- Recommended Reading from the NIH Critical Care Medicine Fellows
@atscommunity
The Blue Journal thanks Amjad N. Kanj, MD, MPH, for his contribution to the January 1 issue
Application of Global Lung Function Initiative Global Spirometry Reference Equations across a Large, Multicenter Pulmonary Function Lab Population
@AmjadKanj
Small Airway Disease in Pre-COPD with Emphysema: A Cross-Sectional Study
Healthy smokers do not exist. This study demonstrates that there is significant small airway loss and remodeling in patients with pre-COPD
@tslapperre
@UAntwerpen
@UZAnieuws
Treatment Mechanism and Inflammatory Subphenotyping in ARDS
The inflammatory subphenotype is clearly a major factor contributing to ARDS heterogeneity, but do not lose sight of the importance of weighing the treatment mechanism to individualize therapy
The Blue Journal thanks Matthew F. Mart, MD, MSc, for his contribution to the April 1 issue
Oxygen-Saturation Targets and Cognitive and Functional Outcomes in Mechanically Ventilated Adults
@MatthewMartMD
@JinHanMD
Using Bayesian Methods to Augment the Interpretation of Critical Care Trials. An Overview of Theory and Example Reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial
🔓 Open Access
🔗
Effect of Esophageal Pressure–guided Positive End-Expiratory Pressure on Survival from Acute Respiratory Distress Syndrome: A Risk-based and Mechanistic Reanalysis of the EPVent-2 Trial
🔗
ERS Special Article: Nasal Positive Airway Pressure and Sleep Apnea. Reflections on an Experimental Method That Became a Therapy, by Colin E. Sullivan
@atscommunity
Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official ATS Research Statement, on behalf of
@ATS_PC
@atscommunity
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
🔓 Open Access
🔗